Brandon Kashfian

Brandon Kashfian is an accomplished professional with a diverse educational background and extensive experience in the pharmaceutical and healthcare industries. He holds a Master of Business Administration (MBA) from The University of Chicago Booth School of Business, a Master of Science (MS) in Neurobiology & Physiology from Northwestern University, and an AB degree as a Phi Beta Kappa scholar from Colby College. Additionally, he pursued further studies at The University of Chicago Pritzker School of Medicine.

Brandon's career highlights include serving as the Founder & Chief Business Officer at AltaThera Pharmaceuticals, where he also held the role of President & CEO in the past. Prior to this, he contributed his expertise as Director of Business Development & Licensing at Lundbeck and Ovation Pharmaceuticals. With a solid financial background, Brandon has worked as a Venture Capital Associate at William Blair Capital Partners LLC and an Investment Banking Associate at J.P. Morgan Chase & Co. (First Chicago Capital Markets). His earlier experience includes research roles at the City of Hope, focusing on medical oncology and biochemical pharmacology.